Rocephin (ceftriaxone) is now approved for acute otitis media

February 1998

    Rocephin (ceftriaxone) is now approved for acute otitis media. It's the first SINGLE-DOSE antibiotic approved for this use.

    A single IM injection of Rocephin works about as well as 10 days of oral amoxicillin...TMP/SMX (Septra, etc)...or cefaclor (Ceclor). But it's LESS effective than 10 days of Augmentin.

    Side effects with Rocephin are similar to using oral antibiotics...usually diarrhea and rash.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote